PH12920A - Composition and method for treatment of hepatic diseases and mental fatigue - Google Patents

Composition and method for treatment of hepatic diseases and mental fatigue

Info

Publication number
PH12920A
PH12920A PH12897A PH12897A PH12920A PH 12920 A PH12920 A PH 12920A PH 12897 A PH12897 A PH 12897A PH 12897 A PH12897 A PH 12897A PH 12920 A PH12920 A PH 12920A
Authority
PH
Philippines
Prior art keywords
treatment
composition
mental fatigue
hepatic diseases
hepatic
Prior art date
Application number
PH12897A
Inventor
P Causa
G Perri
Original Assignee
Richardson Merrell Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell Spa filed Critical Richardson Merrell Spa
Publication of PH12920A publication Critical patent/PH12920A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PH12897A 1970-10-15 1971-10-05 Composition and method for treatment of hepatic diseases and mental fatigue PH12920A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8093670A 1970-10-15 1970-10-15

Publications (1)

Publication Number Publication Date
PH12920A true PH12920A (en) 1979-10-10

Family

ID=22160611

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12897A PH12920A (en) 1970-10-15 1971-10-05 Composition and method for treatment of hepatic diseases and mental fatigue

Country Status (9)

Country Link
AU (1) AU3460571A (en)
BE (1) BE773910A (en)
DE (1) DE2150900A1 (en)
FR (1) FR2110465A1 (en)
GB (1) GB1310658A (en)
IL (1) IL37904A0 (en)
NL (1) NL7114199A (en)
PH (1) PH12920A (en)
ZA (1) ZA716628B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3166142D1 (en) * 1980-06-09 1984-10-25 Leopold & Co Chem Pharm Infusion solution for the protection of the liver and the improvement of its functioning, and process for its production
GB2199243A (en) * 1986-09-17 1988-07-06 Natural Vitality Ltd Pharmaceutical compositions comprising ornithine and arginine
DE3867445D1 (en) * 1987-12-04 1992-02-13 Asta Pharma Ag INJECTABLE SOLUTION OF THE THIOCTSEATE SALT WITH TROMETAMOL AND / OR BASIC AMINO ACIDS.
DK173585B1 (en) * 1989-11-09 2001-04-02 Asta Medica Ag Use of alpha-lipoic acid for the manufacture of a drug for the control of diseases caused by retroviruses
FR2791571B1 (en) * 1999-04-02 2002-10-04 Sod Conseils Rech Applic ASSOCIATION OF NO SYNTHASE INHIBITOR (S) AND METABOLIC ANTIOXIDANT (S)
US9486429B2 (en) 1999-06-01 2016-11-08 Vanderbilt University Therapeutic methods employing nitric oxide precursors
US6346382B1 (en) * 1999-06-01 2002-02-12 Vanderbilt University Human carbamyl phosphate synthetase I polymorphism and diagnostic methods related thereto
CA2399500A1 (en) * 2000-02-01 2001-08-09 Muscletech Research And Development Inc. Alpha lipoic acid based food supplement for increasing lean muscle mass and strength
JP3907964B2 (en) * 2001-04-25 2007-04-18 株式会社 伊藤園 Mental fatigue reducing composition, concentration maintenance enhancing composition and mental vitality maintenance enhancing composition
CA2486879A1 (en) * 2002-05-29 2003-12-04 Unilever Plc Odor control in amine salt containing cosmetic compositions
PL1824563T3 (en) 2004-11-26 2010-07-30 Ucl Business Plc Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
US7932288B2 (en) 2005-10-04 2011-04-26 Kyowa Hakko Bio Co., Ltd. Composition for relieving subjective symptoms of fatigue
EP2050444B1 (en) * 2006-06-07 2011-05-11 Kyowa Hakko Bio Co., Ltd. Fatigue-reducing agent
US8945655B2 (en) 2007-07-10 2015-02-03 Conopco, Inc. Stable and consumable compositions
RU2528097C2 (en) 2008-01-31 2014-09-10 Вандербилт Юнивёсити Methods and formulations for treating subarachnoidal haemorrhage of coronary and arterial aneurism
SG174982A1 (en) 2009-04-03 2011-11-28 Ocera Therapeutics Inc L-ornithine phenyl acetate and methods of making thereof
JP5749255B2 (en) 2009-06-08 2015-07-15 ユーシーエル ビジネス ピーエルシー Treatment of portal hypertension and repair of liver function using L-ornithine phenylacetate
JP6087284B2 (en) 2010-10-06 2017-03-01 オセラ セラピューティクス， インコーポレイテッド Process for producing L-ornithine phenylacetate
IL281349B (en) 2014-11-24 2022-09-01 Ucl Business Ltd Treatment of diseases associated with hepatic stellate cell activation using ammonia-lowering therapies
US10835506B2 (en) 2015-08-18 2020-11-17 Ocera Therapeutics, Inc. Treatment and prevention of muscle loss using L-ornithine in combination with at least one of phenylacetate and phenylbutyrate
CA3063134A1 (en) 2017-05-11 2018-11-15 Ocera Therapeutics, Inc. Processes of making l-ornithine phenylacetate

Also Published As

Publication number Publication date
IL37904A0 (en) 1971-12-29
FR2110465A1 (en) 1972-06-02
NL7114199A (en) 1972-04-18
ZA716628B (en) 1972-06-28
AU3460571A (en) 1973-04-19
GB1310658A (en) 1973-03-21
DE2150900A1 (en) 1972-04-20
BE773910A (en) 1972-01-31

Similar Documents

Publication Publication Date Title
PH12920A (en) Composition and method for treatment of hepatic diseases and mental fatigue
ZA718284B (en) Method and apparatus for the continuous treatment of fibrous materials
IL37098A0 (en) Skin treatment composition and its preparation
PH10336A (en) Nono-chromone-2-carboxylic acid and method and composition for the treatment of asthma
IL36021A (en) Process and apparatus for the continuous treatment of threads
ZA728567B (en) Method and compositions for the treatment of human hair
CS190371B2 (en) Means for destroying the phytopatogenous organism and method of making the active agents
ZA713249B (en) Therapeutic process and compositions
ZA713073B (en) Anthelmintic composition and method of use
BE765352A (en) METHOD AND COMPOSITION FOR THE TREATMENT OF
IL37953A0 (en) Substituted oxazepines and method of use
AU458749B2 (en) Process for the treatment and care of dentures
PH12038A (en) Composition containing cyclobenzaprine for use in the treatment of skeletal muscle disorders and method of treatmen
AU464700B2 (en) Composition and method of treatment
AU462834B2 (en) Pharmaceutical composition and method of treatment
BE774917A (en) COMPOSITION FOR THE TREATMENT OF THE HAIR AND METHOD FOR PREPARING THIS COMPOSITION
CH537160A (en) Equipment for fermentation and / or heat treatment of tobacco
IL37923A0 (en) Process for the treatment of dentures with silicon oil
IE35467B1 (en) Treatment of fats and oils
CA837050A (en) Method of and composition for the treatment of human carcinoma and hypercholestrolemia
ZA708706B (en) Antheilmintic composition and method of use
ZA711821B (en) Pharmaceutical compositions and methods of treatment
ZA71461B (en) Method of treating parkinson's disease
ZA714297B (en) Process for the treatment of woollen material and blends thereof
ZA711291B (en) Treatment of anaplasmosis in cattle